AVL Global, Inc. (OTC: AVLL) is pleased to announce that it is moving forward with the intended merger between itself and Xian Chongyang Biological Sci-tech Stock Co, Ltd. The merger and share exchange agreements have been signed. Legal council for both companies is now preparing the closing documents which are expected to be signed and the deal concluded before the end of October, 2005.
The Chongyang Group is the manufacturer of a line of herbal medicines and reported sales in excess of $8 million USF with net profits in excess of $2 million USF for the 2004 yearend.
The management of AVL expresses great confidence in the value this merger will bring to our shareholders. It is a major change in focus for AVL but will offer new and major growth opportunities for all shareholders as we venture into this exciting new market.
Additional information will be forthcoming.
Source: Market Wire (October 6, 2005 - 10:20 AM EDT)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.